WHO takes new look at avian flu diagnostics
This article was originally published in Clinica
The World Health Organization (WHO) is preparing to issue new diagnostic guidelines for avian flu, after Viet Nam concluded that the death of two children around a year ago may have been due to an atypical and more virulent form of the disease. The situation has prompted concerns that similar cases may until now have gone unnoticed and that the virulence of the virus, its capacity to affect the human body and, ultimately, the risk of human-to-human transmission may all have been underestimated significantly.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.